Novavax, Inc.

NVAX · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders5.1%

Institutions68.9%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$1.12B	$682.16M	$983.71M	$1.98B	$1.15B	$475.60M	$18.66M	$34.29M	$31.18M	$15.35M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$73.04M	$202.74M	$343.77M	$902.64M	–	–	–	–	–	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$452.80M	-$248.93M	-$566.51M	-$644.74M	-$1.69B	-$416.72M	-$120.58M	-$173.92M	-$171.71M	-$269.11M
Operating income as a percentage of revenue.	40.3%	-36.5%	-57.6%	-32.5%	-147.1%	-87.6%	-646.1%	-507.2%	-550.8%	-1752.8%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$440.30M	-$187.50M	-$545.10M	-$657.90M	-$1.74B	-$418.26M	-$132.69M	-$184.75M	-$183.77M	-$279.97M
Net income divided by the number of shares outstanding — profit attributable to each share.	$2.72	$-1.00	$-5.00	$-8.00	$-23.44	$-7.27	$-5.00	$0.00	$0.00	$-1.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$2.58	$-1.00	$-5.00	$-8.00	$-23.44	–	–	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$240.63M	$530.23M	$568.50M	$1.34B	$1.52B	$553.40M	$78.82M	$70.15M	$106.31M	$144.35M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$1.18B	$1.56B	$1.80B	$2.26B	$2.58B	–	$172.96M	$207.98M	$302.49M	$394.30M
All of the company's interest-bearing borrowings, short and long term combined.	–	–	$0	$324.88M	–	–	–	–	–	$0
Everything the company owes — debt, unpaid bills, and other obligations.	$1.30B	$2.18B	$2.51B	$2.89B	$2.93B	–	$358.97M	$375.91M	$404.23M	$399.85M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	-$127.75M	-$623.84M	-$716.93M	-$634.08M	-$351.67M	–	-$186.02M	-$167.94M	-$101.73M	-$5.55M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$244.60M	-$87.30M	-$714.00M	-$415.90M	$322.95M	-$42.54M	-$136.62M	-$184.82M	-$138.70M	-$255.47M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$5.56M	$13.06M	$53.77M	$89.06M	$57.49M	$54.62M	$1.86M	$1.37M	$4.19M	$18.21M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$250.16M	-$100.36M	-$767.77M	-$504.96M	$265.46M	-$97.16M	-$138.48M	-$186.20M	-$142.88M	-$273.68M

	You	Peer avg
Revenue Growth	-76.3%	-46.2%
ROE	–	-480.3%

Novavax, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison